Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Garcia-Escobar, I; Brozos-Vazquez, E; Abad, DG; Martinez-Marin, V; Pachon, V; Martin, AJM; Canc Thrombosis Sect Spanish.

Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence

Clinical & Translational Oncology. 2021; 23(6): 1034-1046 Nº de citas: 8 [doi:10.1007/s12094-020-02506-4]

Taboada AGM; Lominchar PL; Roman LM; García-Alfonso P; Martin AJM; Rodriguez JAB; Pascual JMA.

Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades.

Annals of Hepato-Biliary-Pancreatic Surgery. 2021; 25(2): 179-191 Nº de citas: 17 [doi:10.14701/ahbps.2021.25.2.179]

Loibl, S; Marme, F; Martin, M; Untch, M; Bonnefoi, H; Kim, SB; Bear, H; McCarthy, N; Olive, MM; Gelmon, K; Garcia-Saenz, J; Kelly, CM; Reimer, T; Toi, M; Rugo, HS; Denkert, C; Gnant, M; Makris, A; Koehler, M; Huang-Bartelett, C; Frean, MJL; Colleoni, M; Werutsky, G; Seiler, S; Burchardi, N; Nekljudova, V; von Minckwitz, G.

Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial

JOURNAL OF CLINICAL ONCOLOGY. 2021; 39(14): 1518-1530 Nº de citas: 283 [doi:10.1200/JCO.20.03639]

Majem, M; Manzano, JL; Marquez-Rodas, I; Mujika, K; Munoz-Couselo, E; Perez-Ruiz, E; de la Cruz-Merino, L; Espinosa, E; Gonzalez-Cao, M; Berrocal, A.

SEOM clinical guideline for the management of cutaneous melanoma (2020)

Clinical & Translational Oncology. 2021; 23(5): 948-960 Nº de citas: 20 [doi:10.1007/s12094-020-02539-9]

del Alba, AG; Mendez-Vidal, MJ; Vazquez, S; Castro, E; Climent, MA; Gallardo, E; Gonzalez-Billalabeitia, E; Lorente, D; Maroto, JP; Arranz, JA.

SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)

Clinical & Translational Oncology. 2021; 23(5): 969-979 Nº de citas: 22 [doi:10.1007/s12094-021-02561-5]

Gomez-Espana, MA; Montes, AF; Garcia-Carbonero, R; Mercade, TM; Maurel, J; Martin, AM; Pazo-Cid, R; Vera, R; Carrato, A; Feliu, J.

SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)

Clinical & Translational Oncology. 2021; 23(5): 988-1000 Nº de citas: 40 [doi:10.1007/s12094-021-02573-1]

Alvarez, YE; Bataller, RD; Altozano, JP; Martinez, SR; Alvarez, AS; Cordellat, AB; Vazquez, EB; Jaime, JC; Escobar, IG; Zambrano, CB.

SEOM clinical guidelines for anaemia treatment in cancer patients (2020)

Clinical & Translational Oncology. 2021; 23(5): 931-939 Nº de citas: 21 [doi:10.1007/s12094-021-02580-2]

Verso, M; Munoz, A; Bauersachs, R; Huisman, MV; Mandala, M; Vescovo, G; Becattini, C; Agnelli, G.

Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism

EUROPEAN JOURNAL OF CANCER. 2021; 148: 371-381 Nº de citas: 52 [doi:10.1016/j.ejca.2021.02.026]

Escobar-Alvarez, Y; de Castro-Carpeno, J; Feyjoo, M; Martin-Algarra, S.

Evaluation of patient quality care in Spain in prevention of nausea and vomiting induced by chemotherapy

Journal of Healthcare Quality Research. 2021; 36(3): 142-149 [doi:10.1016/j.jhqr.2021.01.001]

Martin, M; Mayer, IA; Walenkamp, AME; Lapa, C; Andreeff, M; Bobirca, A.

At the bedside: Profiling and treating patients with CXCR4-expressing cancers

JOURNAL OF LEUKOCYTE BIOLOGY. 2021; 109(5): 953-967 Nº de citas: 25 [doi:10.1002/JLB.5BT1219-714R]

Ferre, AD; Alvarez, RA; Herraez, AC; Jurado, JC; Gonzalez, AE; Martin-Broto, J; Marin, VM; Vega, AM; Garcia, AS; Morales, CV.

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)

Clinical & Translational Oncology. 2021; 23(5): 922-930 Nº de citas: 37 [doi:10.1007/s12094-020-02534-0]

Trilla-Fuertes, L; Gamez-Pozo, A; Maurel, J; Garcia-Carbonero, R; Capdevila, J; G-Pastrian, L; Mendiola, M; Pena, C; Lopez-Vacas, R; Cuatrecasas, M; Garcia-Alfonso, P; Ramos-Ruiz, R; Llorens, C; Ghanem, I; Conill, C; Heredia-Soto, V; Campos-Barros, A; Vara, JAF; Feliu, J.

Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab

Scientific Reports. 2021; 11(1): 7402-7402 Nº de citas: 3 [doi:10.1038/s41598-021-86966-w]

Conde, E; Earl, J; Crespo-Toro, L; Blanco-Agudo, C; Ramos-Munoz, E; Rodriguez-Serrano, EM; Avila, JCM; Salinas-Munoz, L; Serrano-Huertas, S; Ferreiro, R; Rodriguez-Garrote, M; Sainz, B; Massuti, B; Alfonso, PG; Benavides, M; Aranda, E; Garcia-Bermejo, ML; Carrato, A.

Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study

Cancers. 2021; 13(7): Nº de citas: 14 [doi:10.3390/cancers13071710]

Morgan, G; Tagliamento, M; Lambertini, M; Devnani, B; Westphalen, B; Dienstmann, R; Bozovic-Spasojevic, I; Calles, A; Criscitiello, C; Curioni, A; Garcia, AM; Lamarca, A; Pilotto, S; Scheffler, M; Strijbos, M; Wong, R; de Azambuja, E; Peters, S.

Impact of COVID-19 on social media as perceived by the oncology community: results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert Network

ESMO Open. 2021; 6(2): 100104-100104 Nº de citas: 20 [doi:10.1016/j.esmoop.2021.100104]

Sastre, J; Garcia-Alfonso, P; Vieitez, JM; Cano, MT; Rivera, F; Reina-Zoilo, JJ; Salud-Salvia, A; Quintero, G; Robles-Diaz, L; Safont, MJ; La Casta, A; Gil, S; Polo, E; Asensio-Martinez, E; Garcia-Paredes, B; Lopez, RL; Guillot, M; Valladares-Ayerbes, M; Aranda, E; Diaz-Rubio, E.

Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and < 3 baseline circulating tumour cells: the randomised phase II VISNU-2 study

ESMO Open. 2021; 6(2): 100062-100062 Nº de citas: 11 [doi:10.1016/j.esmoop.2021.100062]

Hecht, JR; Lonardi, S; Bendell, J; Sim, HW; Macarulla, T; Lopez, CD; Van Cutsem, E; Martin, AJM; Park, JO; Greil, R; Wang, H; Hozak, RR; Gueorguieva, I; Lin, Y; Rao, S; Ryoo, BY.

Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA)

JOURNAL OF CLINICAL ONCOLOGY. 2021; 39(10): 1108 Nº de citas: 87 [doi:10.1200/JCO.20.02232]

Palka-Kotlowska, M; Custodio-Cabello, S; Oliveros-Acebes, E; Khosravi-Shahi, P; Cabezon-Gutierrez, L.

Review of risk of COVID-19 in cancer patients and their cohabitants

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2021; 105: 15-20 Nº de citas: 3 [doi:10.1016/j.ijid.2021.01.072]

Garcia-Alfonso, P; Martin, AJ; Moran, L; Alsar, J; Perez-Solero, G; Codesido, M; Ferrandiz, PA; Cicala, S.

Oral drugs in the treatment of metastatic colorectal cancer

Therapeutic Advances in Medical Oncology. 2021; 13: Nº de citas: 48 [doi:10.1177/17588359211009001]